The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Large Increase in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 10,500 shares, an increase of 7.1% from the October 15th total of 9,800 shares. Based on an average trading volume of 22,700 shares, the short-interest ratio is currently 0.5 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Down 0.3 %

Shares of NASDAQ CGABL traded down $0.05 during trading on Monday, hitting $19.41. The company had a trading volume of 21,155 shares, compared to its average volume of 21,876. The stock has a 50 day simple moving average of $19.87 and a 200 day simple moving average of $19.01. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12 month low of $17.04 and a 12 month high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, November 15th. Shareholders of record on Saturday, November 1st will be issued a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a yield of 5.96%. The ex-dividend date of this dividend is Friday, October 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.